ImmunoGen Inc
Change company Symbol lookup
Select an option...
IMGN ImmunoGen Inc
WAB Westinghouse Air Brake Technologies Corp
JCI Johnson Controls International PLC
RYT Invesco S&P 500® Equal Weight Technology ETF
SIRI Sirius XM Holdings Inc
CLWA Fuzebox Software Corp
MDDNF Meridian Energy Ltd
BAC Bank of America Corp
TGT Target Corp
GDXJ VanEck Vectors Junior Gold Miners ETF
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its product candidates include Mirvetuximab soravtansine; IMGN779; IMGN632; and Coltuximab ravtansine. Its portfolio is led by Mirvetuximab soravtansine, a first-in-class ADC targeting folate-receptor alpha (Fra), which is in a Phase III registrational trial called FORWARD I. Its FORWARD II trial consists of cohorts assessing Mirvetuximab soravtansine in combination with Avastin (bevacizumab), Keytruda (pembrolizumab) and carboplatin. The Company has developed tubulin-acting maytansinoid payload agents, which include DM1 and DM4, as well as deoxyribonucleic acid (DNA)-alkylating agents called IGNs.

Postmarket

Last Trade
Delayed
$2.29
0.01 (0.44%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.28
Day's Change
-0.20 (-8.06%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.50
Day's Low
2.25
Volume
(Average)
Volume:
2,512,600

10-day average volume:
2,492,961
2,512,600
  • Prev Close
    2.48
  • Today's Open
    2.48
  • Day's Range
    2.25-2.50
  • Avg Vol (10-day)
    2.5M
  • Last (time)
    4:00p ET 07/16/19
  • Last (size)
    551
  • 52-Wk Range
    1.76 - 10.39
    LowHigh
  • (07/23/18 - 05/31/19)
    29.55%
  • 104.0%
  • Market Cap
    340.9M
  • Shares Outstanding
    149.5M
  • -1.21
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.3
  • 75.21
  • (% of float 06/28/19)
    4.84

Latest News

June 27, 2019
6:30 am ET
BusinessWire
May 29, 2019
4:52 pm ET
Globe Newswire
May 15, 2019
5:45 pm ET
Globe Newswire
5:01 pm ET
BusinessWire
7:49 am ET
MarketWatch
6:30 am ET
BusinessWire
May 08, 2019
8:01 am ET
Globe Newswire
May 06, 2019
9:00 am ET
Globe Newswire
May 03, 2019
6:30 am ET
BusinessWire
April 18, 2019
4:30 pm ET
BusinessWire
March 19, 2019
6:55 am ET
MarketWatch
March 05, 2019
9:55 am ET
MarketWatch
March 01, 2019
9:50 am ET
MarketWatch
9:49 am ET
MarketWatch
8:20 am ET
MarketWatch
8:20 am ET
MarketWatch
6:42 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.